Skip to main content
. 2022 Jan 6;42(1):BSR20211783. doi: 10.1042/BSR20211783

Figure 3. The relationship of MTHFD1L expression with different clinicopathological features of BLCA.

Figure 3

(A) Expression of MTHFD1L in different cancer stages of BLCA patients, (B) expression of MTHFD1L in different races of BLCA patients, (C) expression of MTHFD1L in different genders of BLCA patients, and (D) expression of MTHFD1L in different age groups of BLCA patients. *P<0.05.